Current directions in co-crystal growth.
dc.contributor.author | Blagden, Nicholas | * |
dc.contributor.author | Berry, David J. | * |
dc.contributor.author | Parkin, A. | * |
dc.contributor.author | Javed, Hafsa S. | * |
dc.contributor.author | Ibrahim, Asim | * |
dc.contributor.author | Gavan, Pauline T. | * |
dc.contributor.author | De Matos, Luciana L. | * |
dc.contributor.author | Seaton, Colin C. | * |
dc.date.accessioned | 2011-03-23T15:50:39Z | |
dc.date.available | 2011-03-23T15:50:39Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | Blagden N, Berry DJ, Parkin A et al (2008) Current directions in co-crystal growth. New journal of chemistry. 32(10): 1659-1672. | |
dc.identifier.uri | http://hdl.handle.net/10454/4848 | |
dc.description | No | |
dc.description.abstract | In this feature article we will focus on the issues relating to the crystal growth of co-crystals, with a particular emphasis on drug development. The initial focus of this perspective is on the relevant literature examples that may be able to inform our understanding with regards co-crystal crystallisation and the allied supramolecular concepts. The second part of this perspective contains selected examples from our own work, which add to the literature perspective. Topics include; nucleation templates, in situ synchrotron XRD studies, solid-state synthesis through mixing and screening strategies. | |
dc.language.iso | en | |
dc.subject | Crystal engineering | |
dc.subject | Crystal growth | |
dc.subject | Co-crystals | |
dc.subject | Drug development | |
dc.subject | Crystallisation | |
dc.title | Current directions in co-crystal growth. | |
dc.status.refereed | Yes | |
dc.type | Article | |
dc.type.version | No full-text in the repository | |
dc.identifier.doi | https://doi.org/10.1039/B803866J | |
dc.openaccess.status | closedAccess |